Brandywine Oak Private Wealth LLC Sells 143 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Brandywine Oak Private Wealth LLC trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,426 shares of the financial services provider’s stock after selling 143 shares during the quarter. Brandywine Oak Private Wealth LLC’s holdings in iShares Biotechnology ETF were worth $453,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of IBB. Huntington National Bank lifted its stake in shares of iShares Biotechnology ETF by 17.9% in the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after buying an additional 160 shares in the last quarter. National Bank of Canada FI lifted its position in iShares Biotechnology ETF by 5.9% in the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after acquiring an additional 229 shares in the last quarter. Avior Wealth Management LLC boosted its stake in iShares Biotechnology ETF by 438.2% during the 3rd quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock valued at $470,000 after purchasing an additional 2,629 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares in the last quarter. Finally, Main Management ETF Advisors LLC raised its stake in shares of iShares Biotechnology ETF by 2.5% in the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after purchasing an additional 14,535 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 2.5 %

NASDAQ IBB opened at $142.33 on Thursday. The company has a fifty day moving average price of $136.31 and a 200-day moving average price of $141.47. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.